S1 Ep37: ESC 2026 Hot Line Recap: 3 Trials Every Pharmacist Needs
CARDIO-TTRansform — eplontersen in transthyretin amyloid cardiomyopathy (ATTR-CM). ClinicalTrials.gov: NCT04136171SINGLE-AF — direct oral anticoagulation in patients with atrial fibrillation at intermediate stroke risk. ClinicalTrials.gov: NCT04437654POET II — response-tailored, shortened antibiotic therapy in left-sided infective endocarditis. ClinicalTrials.gov: NCT03851575
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest
S2 Ep93: Insights from ESC: Treat Earlier, Implement Better, and Question What We Thought We Knew
36: 2026 ACC Consensus Pathway Redefines HFpEF Diagnosis, Treatment Priorities
35: Deprescribing in Cardiovascular Disease: A New AHA Roadmap for Tackling Polypharmacy
34: Putting the 2026 CKM Guidelines Into Practice: A Pharmacist's Perspective
Get summaries like this every morning.
Free AI-powered recaps of The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.